vimarsana.com

Latest Breaking News On - Geoffrey mogilner - Page 5 : vimarsana.com

Olema Oncology Announces Positive Phase 2 Monotherapy

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant
forextv.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from forextv.com Daily Mail and Mail on Sunday newspapers.

Olema Oncology Announces Positive Phase 2 Monotherapy Clinical Study Results for Palazestrant - Olema Pharmaceuticals (NASDAQ:OLMA)

Across all 86 heavily pretreated patients, the median PFS was 4.6 months with a CBR of 40%; in patients with ESR1 mutations at baseline, the median PFS was 5.6 months with a CBR of 52% In an analysis of 49 second- and

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.